Effects of Empagliflozin Treatment on Cardiac Biomarkers in Adults With Metabolically Healthy Obesity: Results From a Randomized, Placebo-Controlled Clinical Trial.

ABSTRACT:

SUBMITTER: Khan SS 

PROVIDER: S-EPMC8446809 | biostudies-literature | 2021 Aug

REPOSITORIES: biostudies-literature